scholarly article | Q13442814 |
P2093 | author name string | M Nakamura | |
T Morisaki | |||
K Miyazaki | |||
K Fujimoto | |||
M Katano | |||
P2860 | cites work | A role for platelet-derived growth factor in normal gliogenesis in the central nervous system | Q48087702 |
Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops | Q48478557 | ||
A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. | Q51034462 | ||
Growth factors: Mechanism of action and relation to oncogenes | Q53552812 | ||
Presence of Elevated Levels of Platelet-Derived Growth Factor (PDGF) in Lung Adenocarcinoma Pleural Effusions | Q67491575 | ||
Biology of tumour metastasis | Q67537225 | ||
Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time | Q68182554 | ||
Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy | Q68957965 | ||
Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small-cell human lung carcinoma lines | Q69823540 | ||
Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms | Q70487513 | ||
Prognostic value of vascular endothelial growth factor expression in gastric carcinoma | Q71018131 | ||
Usefulness of platelet-derived growth factor as a prognostic factor in pulmonary adenocarcinoma | Q71668887 | ||
A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens | Q73554965 | ||
cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines | Q24299707 | ||
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor | Q28236903 | ||
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo | Q29614729 | ||
Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines | Q34339034 | ||
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice | Q34342812 | ||
Platelet-derived growth factor. Structure, function, and roles in normal and transformed cells | Q34612848 | ||
Lymph node metastases of gastric cancer. General pattern in 1931 patients | Q34680739 | ||
Function of a human cyclin gene as an oncogene | Q34994859 | ||
Platelet-derived growth factor in human malignancy | Q35229137 | ||
PDGF ligand and receptor gene expression during repair of arterial injury | Q36223935 | ||
Metalloproteinase domain structure, cellular invasion and metastasis | Q40764344 | ||
Expression of interleukin 10 in human melanoma. | Q42067641 | ||
Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin | Q42756248 | ||
Induction of growth factor RNA expression in human malignant melanoma: markers of transformation | Q42807860 | ||
Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival | Q44680447 | ||
Evaluation of the TNM classification of stomach cancer and proposal for its rational stage-grouping. | Q45116699 | ||
Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: Correlation with stage and rate of progression | Q46973426 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 365-371 | |
P577 | publication date | 1998-03-01 | |
P1433 | published in | Annals of Surgery | Q4767866 |
P1476 | title | Prognostic value of platelet-derived growth factor-A (PDGF-A) in gastric carcinoma | |
P478 | volume | 227 |
Q48207420 | "Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer. |
Q43830000 | A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer |
Q33951007 | Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer |
Q73699210 | Expression of melanoma antigen-encoding gene-1 predicts lymph node involvement in early gastric carcinomas |
Q42682692 | MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer. |
Q33407676 | Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer |
Q86445750 | Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer |
Q33389519 | Phase II study of sunitinib as second-line treatment for advanced gastric cancer |
Q39325255 | Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma |
Q30250273 | Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers |
Q33406697 | Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer |
Q33388995 | Pulmonary thrombotic microangiopathy caused by gastric carcinoma |
Q36875450 | Reduction in circulating pro-angiogenic and pro-inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega-3 fish oil. |
Q28242840 | Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy |
Q28740616 | TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma |
Q40639082 | Tumor infiltration pattern into the surrounding tissue has prognostic significance in advanced gastric cancer |
Q34425709 | Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma |
Q54606278 | VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery. |
Search more.